| __timestamp | Gilead Sciences, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 382096000000 |
| Thursday, January 1, 2015 | 3014000000 | 345927000000 |
| Friday, January 1, 2016 | 5098000000 | 312303000000 |
| Sunday, January 1, 2017 | 3734000000 | 325441000000 |
| Monday, January 1, 2018 | 5018000000 | 368298000000 |
| Tuesday, January 1, 2019 | 9106000000 | 492381000000 |
| Wednesday, January 1, 2020 | 5039000000 | 455833000000 |
| Friday, January 1, 2021 | 5363000000 | 526087000000 |
| Saturday, January 1, 2022 | 4977000000 | 633325000000 |
| Sunday, January 1, 2023 | 6923000000 | 729924000000 |
| Monday, January 1, 2024 | 5907000000 | 729924000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, innovation is the lifeblood that drives progress. Gilead Sciences, Inc. and Takeda Pharmaceutical Company Limited are two titans in this field, each with a distinct approach to research and development (R&D) investment. Over the past decade, Takeda has consistently outpaced Gilead, investing nearly 100 times more in R&D by 2023. While Gilead's R&D expenses peaked in 2019, reaching approximately $9 billion, Takeda's investment has shown a steady upward trend, culminating in a staggering $730 billion in 2023. This stark contrast highlights Takeda's commitment to innovation, despite Gilead's significant contributions. The data from 2014 to 2023 reveals a fascinating narrative of strategic priorities and financial commitment, with Takeda's R&D spending growing by over 90% during this period. As we look to the future, these investments will likely shape the landscape of pharmaceutical advancements.
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Viatris Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and BeiGene, Ltd.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and MorphoSys AG
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc.